Innovent Biologics, Inc. (6IB.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
At close: 09:59AM CEST
Currency in EUR
Valuation Measures4
| Market Cap (intraday) | 7.59B |
| Enterprise Value | 6.77B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 9.17 |
| Price/Book (mrq) | 4.72 |
| Enterprise Value/Revenue | 8.57 |
| Enterprise Value/EBITDA | -2.32 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.17 |
| 52-Week Change 3 | 3.57% |
| S&P500 52-Week Change 3 | 26.36% |
| 52 Week High 3 | 5.6500 |
| 52 Week Low 3 | 3.2400 |
| 50-Day Moving Average 3 | 4.3968 |
| 200-Day Moving Average 3 | 4.4909 |
Share Statistics
| Avg Vol (3 month) 3 | 8 |
| Avg Vol (10 day) 3 | N/A |
| Shares Outstanding 5 | 1.62B |
| Implied Shares Outstanding 6 | 1.64B |
| Float 8 | 1.41B |
| % Held by Insiders 1 | 7.05% |
| % Held by Institutions 1 | 52.46% |
| Shares Short 4 | N/A |
| Short Ratio 4 | N/A |
| Short % of Float 4 | N/A |
| Short % of Shares Outstanding 4 | N/A |
| Shares Short (prior month ) 4 | N/A |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Currency in CNY.Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | -16.56% |
| Operating Margin (ttm) | -24.11% |
Management Effectiveness
| Return on Assets (ttm) | -5.11% |
| Return on Equity (ttm) | -8.84% |
Income Statement
| Revenue (ttm) | 6.21B |
| Revenue Per Share (ttm) | 3.98 |
| Quarterly Revenue Growth (yoy) | 51.30% |
| Gross Profit (ttm) | N/A |
| EBITDA | -1.29B |
| Net Income Avi to Common (ttm) | -1.03B |
| Diluted EPS (ttm) | -0.0800 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 10.97B |
| Total Cash Per Share (mrq) | 6.76 |
| Total Debt (mrq) | 3.62B |
| Total Debt/Equity (mrq) | 28.90% |
| Current Ratio (mrq) | 3.00 |
| Book Value Per Share (mrq) | 7.72 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 147.81M |
| Levered Free Cash Flow (ttm) | -907.54M |
© 2024 Yahoo. All rights reserved.